Skip to page content

Indigo Ag cuts 80 jobs in Boston, Memphis


Tractor harvesting Indigo Cotton
A tractor harvesting Indigo Cotton.
Bob Bayne

Months after raising a multimillion-dollar funding round, one of Boston's so-called "unicorn" companies is cutting dozens of jobs.

Boston-based Indigo Ag Inc., an agriculture-technology startup that uses microbiology research to help farmers replace chemicals and fertilizers and increase crop yield, is cutting 80 jobs across its Boston and Memphis locations, as well as remote roles, the company told the Business Journal.

Liz Graham, COO of Indigo Ag, wrote in an email that the jobs eliminated are across the board, with the reductions taking effect on Tuesday.

In an emailed fact sheet, Indigo said that 25 roles were eliminated in Boston, 29 in Memphis and 26 among remote employees. Following the cuts, Indigo's total headcount will be at over 1,000 people across the U.S., with 472 people employed in Boston and 242 in Memphis, according to Graham.

The news of the cuts comes approximately six months after Indigo raised one of the top Massachusetts venture capital deals of 2020, a $535 million Series F round that included a previously announced $175 million in convertible equity. Indigo’s total capital raised to date is more than $1.1 billion.

Indigo also cut 150 staff members in February last year, shortly after raising $200 million from new investor FedEx and new lender Pacific Western Bank.

Indigo attributed the latest decision to eliminate jobs to new CEO Ron Hovsepian’s focus "to direct resources to four primary offerings and realize the value they can deliver to the industry," the company said in a statement. Indigo’s four offerings are a grain marketing platform, a transportation platform, a carbon farming program and biological products.

Hovsepian became chief executive in September 2020, after serving as acting COO. He succeed David Perry, who was CEO since 2014.

Indigo declined an interview request. Graham said in a statement that "Ron’s focus on operational efficiency is clarifying how we map our resources to our offerings. This allows Indigo to execute faster and scale our business model to deliver exponentially more value to our stakeholders and affect change in the industry."

Indigo Ag first hit unicorn status — a $1 billion valuation — in 2017, after raising $156 million in Series D financing.

Stéphane Bancel, CEO of Cambridge Covid vaccine maker Moderna Inc. (Nasdaq: MRNA), joined the board of Indigo last year, approximately one month before Hovsepian's appointment.


Keep Digging



SpotlightMore

See More
See More
See More
See More

Upcoming Events More

Nov
28
TBJ
Oct
10
TBJ
Oct
29
TBJ

Want to stay ahead of who & what is next? Sent daily, the Beat is your definitive look at Boston’s innovation economy, offering news, analysis & more on the people, companies & ideas driving your city forward. Follow the Beat.

Sign Up